Cancer 2025

Refine the list (min. 2 characters)

Keynote Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Personalized and Precision Medicine (PPM) through the view of biodesign-inspired translational research: An option for clinical oncologists, caregivers and consumers to realize the potential of genomics-informed care to secure the human biosafety

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). Meanwhile, the era of genomics-based medicine and thus genomics biomarkers promises to provide molecular tests that will pe [....] » Read More

Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Keynote Presentation (In-Person)

Subhash C Kundu, Speaker at Oncology Conference

Title: 3D in vitro cancer models using natural biomaterials for studying the cancer microenvironment and drug screening

Recreating the complexity of the tumor microenvironment is essential for advancing cancer research. Three-dimensional (3D) biomaterials offer a powerful platform for replicating the biological, chemical, and mechanical properties of native tissues, providing a more physiologicall [....] » Read More

Subhash C Kundu, 3Bs Research Group, I3Bs – Research Institute of University of Minho, Portugal

Keynote Presentation (In-Person)

Yan-Shen Shan, Speaker at Oncology Conference

Title: Hypoxia-Fibrosis cycle in pancreatic cancer reveals potential pathways associated with tumor progression and predicts poor prognosis

Pancreatic cancer (PC) is difficult to treat and has the lowest five-year survival rate across the world. PC is characterized by desmoplasia composed of abundant cancer-associated fibroblasts (CAFs) and excessive extracellular matrix (ECM), which creates a pathological barrier th [....] » Read More

Yan-Shen Shan, National Cheng Kung University Hospital, Taiwan

Keynote Presentation (In-Person)

Thomas J. Webster, Speaker at Cancer Science and Research Conference

Title: Anti-Cancer nanomedicine in humans: 30,000 successful cases and counting

This presentation will cover a close to 30 year journey researching and commercializing nanotechnology for improving disease prevention, diagnosis, and treatment (including cancer) which has led to numerous products including nano spinal implants now in over 30,000 patients to da [....] » Read More

Thomas J. Webster, Brown University, United States

Oral Presentation (In-Person)

Salah S. Massoud, Speaker at Oncology Conference

Title: Copper(II) complexes as potent chemotherapeutic agents for anticancer therapy

Cancer is the second top leading cause of death worldwide. According to WHO, approximately 10 million individuals died of cancer in 2022, and this number is expected to rise to 16.4 million by 2040. Since the FDA approval of cisplatin as a chemotherapeutic drug for cancer treatme [....] » Read More

Salah S. Massoud, University of Louisiana, United States

Oral Presentation (In-Person)

Ren-Wang Peng, Speaker at Cancer Science and Research Conference

Title: Lactate dehydrogenase B noncanonically promotes ferroptosis defense in KRAS-driven lung cancer

Ferroptosis is an oxidative, non-apoptotic form of cell death that is frequently inactivated in cancer, yet its regulation in oncogene-specific tumors remains poorly understood. Here, we identify lactate dehydrogenase B (LDHB)—but not the closely related LDHA—as a non [....] » Read More

Ren-Wang Peng, University of Bern, Switzerland

Oral Presentation (In-Person)

Nira Ben Jonathan, Speaker at Oncology Conference

Title: Suppression of breast cancer by small molecules that block the prolactin receptor

Background: Prolactin (PRL) is a protein hormone whose main production site is the pituitary gland. In humans, however, PRL is produced and secreted not only by the pituitary but also by other cells such as adipocytes, lymphocytes and mammary cells. The PRL receptor (PRLR) belong [....] » Read More

Nira Ben Jonathan, University of Cincinnati, United States

Oral Presentation (In-Person)

Sergey Reva, Speaker at Oncology Conference

Title: Immunological markers as predictors of unfavorable pathomorphological characteristics, an upgrading, upstaging and risk group increase in prostate cancer patients after radical prostatectomy

Background. The role of systemic inflammation in carcinogenesis has been studied for a long time. Markers of systematic inflammation response, such as neutrophil-lymphocyte ratio (NLR), platelet-lymphocyte ratio (PLR) and lymphocyte-monocyte ratio (LMR), are associated with the u [....] » Read More

Sergey Reva, I.P. Pavlov First State Medical University, Saint-Petersburg, Russian Federation

Oral Presentation (In-Person)

Chujie Li, Speaker at Cancer Science and Research Conference

Title: monoHER as a selective radiosensitizer in breast cancer

Background: Radiotherapy is one of the standard treatments for breast cancer, but its efficacy is limited by tumour radioresistance and damage to surrounding normal tissues. In recent years, combining different therapeutic modalities has improved treatment efficacy while minimizi [....] » Read More

Chujie Li, Maastricht University, Netherlands

Oral Presentation (In-Person)

Sergey Suchkov, Speaker at Cancer Science and Research Conference

Title: Personalized and Precision Oncology (PPO) to be set up via precision oncology strategy for cancer care team: Developing targeted cancer therapy & advancing personalized cancer care

A new systems approach to diseased states and wellness result in a new branch in the healthcare services, namely, personalized and precision medicine (PPM). The concept of PPM is becoming increasingly relevant for cancer treatment, moving from the ‘one-size-fits-all’ [....] » Read More

Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation

Oral Presentation (In-Person)

Shadma Fatima, Speaker at Cancer Science and Research Conference

Title: Targeting glioblastoma multiforme through a multifaceted therapeutic drug approach

Being the most aggressive primary brain tumor in adults Glioblastoma multiforme (GBM) represents a formidable challenge for clinicians. Despite multifaceted treatment strategy encompassing surgical intervention, radiation therapy, and chemotherapy, the prognosis for GBM patients [....] » Read More

Shadma Fatima, Western Sydney University, Australia

Oral Presentation (In-Person)

Xue Xiao, Speaker at Cancer Science and Research Conference

Title: Key mechanisms driving extravillous trophoblast lineage imbalance in placenta accreta spectrum

Background:  Placenta Accreta Spectrum (PAS) represents a serious pregnancy complication characterized by abnormal invasion of extravillous trophoblasts (EVTs) into the uterine myometrium, leading to high risks of maternal morbidity and mortality. Although EVTs play a c [....] » Read More

Xue Xiao, Sichuan University, China

Oral Presentation (In-Person)

Venturi Sebastiano, Speaker at Oncology Conference

Title: The controversy of radioactive cesium damage on animal pancreas and diabetes

In these times of danger of severe international conflicts with fear of the use of atomic weapons and accidents  in nuclear power plants, radionuclide contamination in terrestrial ecosystems has nowadays  reached a dangerous level. One of the most frequent and studied a [....] » Read More

Venturi Sebastiano, AUSL-ROMAGNA, Italy

Poster Presentation (In-Person)

Chia-Jung Li, Speaker at Oncology Conference

Title: Functional integration of the ATP synthasome drives mitochondrial efficiency in breast carcinoma

Background: This study investigates the metabolic alterations associated with breast cancer progression and elucidates the underlying mechanisms. Adenine nucleotide translocase 2 (ANT2), a mitochondrial protein essential for cellular energy metabolism, facilitates the exchange of [....] » Read More

Chia-Jung Li, Kaohsiung Veterans General Hospital, Taiwan

Poster Presentation (In-Person)

Biliana Nikolova, Speaker at Oncology Conference

Title: Targeting oral squamous cell carcinoma with thienopyrimidines

Oral squamous cell carcinoma (OSCC) is among the most aggressive and lethal cancers of the head and neck, often diagnosed at an advanced stage and marked by treatment resistance. In search of selective anticancer agents, we evaluated a series of 2-substituted 4-amino-thieno[2,3-d [....] » Read More

Biliana Nikolova, Bulgarian Academy of Sciences, Bulgaria

Poster Presentation (In-Person)

Jianghao Ren, Speaker at Cancer Science and Research Conference

Title: Targeting SIRT7-Mediated DNA damage repair as a novel strategy in pancreatic cancer

Background: Pancreatic cancer is a highly lethal malignancy characterized by poor prognosis and limited therapeutic options. Recent evidence suggests that Sirtuin 7 (SIRT7), a nucleolar NAD?-dependent deacetylase, plays an oncogenic role in multiple cancers; however, its precise [....] » Read More

Jianghao Ren, Zhejiang University, China

Poster Presentation (In-Person)

Cheol Min Lee, Speaker at Cancer Science and Research Conference

Title: Effectiveness of smoking cessation interventions for smokers undergoing lung cancer screening: A systematic review and meta-analysis

Background: Smoking is the leading cause of lung cancer, and smoking cessation is crucial for reducing both the lung cancer incidence and mortality. We aimed to assess the effectiveness of smoking cessation interventions in smokers undergoing lung cancer screening (LDCT). &nbs [....] » Read More

Cheol Min Lee, Seoul National University Hospital Healthcare System, Korea, Republic of

Poster Presentation (In-Person)

Davoud Shojaeizadeh, Speaker at Cancer Conferences

Title: The impact of social marketing based intervention on educating esophageal cancer preventive behaviors

Esophageal cancer is one of the most widespread disease in Golestan Province, Iran. To identify risk factors a lot of research has been done. Because health workers have successful experiences of health education. The purpose of this study is to use social marketing to influence [....] » Read More

Davoud Shojaeizadeh, Tehran University of Medical Sciences, Iran (Islamic Republic of)

Poster Presentation (In-Person)

Peng Bai, Speaker at Cancer Conferences

Title: Physical activity in endometrial cancer prevention and control: Bridging epidemiological evidence to molecular mechanisms

Background: Since 2007, evidence supporting the role of physical activity (PA) in cancer prevention and survivorship has grown substantially. While early research focused on cancers such as colon, breast, and endometrial, more recent findings have consistently identified PA as a [....] » Read More

Peng Bai, Sichuan University, China

Keynote Presentation (Virtual)

Henrique Manuel dos Santos Faneca, Speaker at Cancer Science and Research Conference

Title: Targeted nanosystems to mediate combined cancer therapy

Hepatocellular carcinoma (HCC) is one of the major causes of cancer mortality worldwide, highlighting the urgent need for the development of new therapeutic approaches, such as those involving the combination of gene therapy and chemotherapy, that potentially present higher thera [....] » Read More

Henrique Manuel dos Santos Faneca, University of Coimbra (CNC-UC), Portugal

Keynote Presentation (Virtual)

Julia Sidorova, Speaker at Oncology Conference

Title: Information leakage: Types, remedies, and open problems

Information Leakage threatens and questions the use of machine learning model in real-life clinical applications. In effect, information leakage is similar to vulgar overfitting, yet rather more subtle and even when detected much harder to remove. Some recent research i [....] » Read More

Julia Sidorova, Instituto Carlos III de Salud (CIBER-EHD), Spain

Keynote Presentation (Virtual)

Paulo Cesar De Morais, Speaker at Oncology Conference

Title: Cell viability assays under radiofrequency application modulated by nanomaterials

In this keynote talk, it will be explored the use of the Hill model to assess the Benchmark dose (BMD), the lethal dose 50 (LD50), the cooperativity (E) and the dissociation constant (K) while analyzing cell viability data using nanomaterials. The presentation is addressed to dis [....] » Read More

Paulo Cesar De Morais, Catholic University of Brasilia, Brazil

Keynote Presentation (Virtual)

Rajvir Dahiya, Speaker at Cancer Science and Research Conference

Title: A novel mRNA genomic technology for precision medicine, cancer diagnosis, prognosis, treatment follow-up

Current screening methods—radiological imaging, DNA-based tests, and pathological assessments—often fail to detect malignancies at early stages. Despite technological advances, gene-based diagnostics specifically designed for early cancer detection remain limited. To [....] » Read More

Rajvir Dahiya, University of California San Francisco School of Medicine, United States

Oral Presentation (In-Person)

Minoo Shahidi, Speaker at Oncology Conference

Title: Resveratrol reduces the presence of Extracellular Traps (ETs) in acute promyelocytic leukemia (NB4) cells

NETosis and ETosis are processes involving the release of extracellular traps (ETs). They have been linked to cancer progression, particularly in promoting metastasis and tumor-associated thrombosis. This indicates that redundant NETs/ETs formation can contribute to cancer spread [....] » Read More

Minoo Shahidi, Iran University of Medical Sciences, Iran (Islamic Republic of)

Oral Presentation (Virtual)

Tenghua Yu, Speaker at Oncology Conference

Title: GPER-driven crosstalk in breast cancer: Bridging drugs resistance and tumor microenvironment remodeling

Triple-negative breast cancer (TNBC) is a particularly aggressive type of breast cancer, known for its lack of effective treatments and unfavorable prognosis. The G protein-coupled estrogen receptor (GPER), a novel estrogen receptor, is linked to increased malignancy in various c [....] » Read More

Tenghua Yu, Jiangxi Cancer Hospital & Institute, China

Oral Presentation (Virtual)

Zheng weihui, Speaker at Cancer Science and Research Conference

Title: Preclinical study on new parathyroid recognition technology in thyroid surgery

Background: The parathyroid gland is the smallest organ in the organism, with an important function of regulating blood calcium in the human body. The accidental resection of the parathyroid gland during thyroid surgery cannot be ignored, so attention should be paid to the identi [....] » Read More

Zheng weihui, Zhejiang Cancer Hospital, China

Oral Presentation (Virtual)

Huynh Yen Phi, Speaker at Oncology Conference

Title: Global trends and predictive factors of prophylactic mastectomy in women: A systematic review and meta-analysis

IMPORTANCE: The prevalence of prophylactic mastectomy is increasing globally despite the aggressiveness of the surgery and its uncertain effectiveness in preventing cancer.   OBJECTIVE: To estimate the global prevalence of prophylactic mastectomy and assess the [....] » Read More

Huynh Yen Phi, Taipei Medical University, Taiwan

Oral Presentation (Virtual)

Alain Chapel, Speaker at Oncology Conference

Title: From experimental research to clinical trial in the treatment of complication of radiotherapy by stem cells

Statement of the problem: The late adverse effects of pelvic radiotherapy concern 5 to 10% of patients, which could be life threatening. However, a clear medical consensus concerning the clinical management of such healthy tissue sequelae does not exist. Our group has demonstrate [....] » Read More

Alain Chapel, Institute of Radiological Protection and Nuclear Safety, France

Oral Presentation (Virtual)

Lorent Sijarina, Speaker at Cancer Science and Research Conference

Title: Is artificial intelligence a possible solution for challenges in healthcare?

Introduction: Healthcare systems are facing mounting challenges from aging populations, increasing patient demand, and chronic disease burdens. Conventional approaches are often insufficient, highlighting the need for innovative tools. Artificial intelligence (AI) has emerged [....] » Read More

Lorent Sijarina, University of Prishtina, Kosovo

Oral Presentation (Virtual)

Constantinos M. Mikelis, Speaker at Oncology Conference

Title: The regulatory role of endothelial RhoA on tumor microenvironment

The endothelial barrier plays an active role in tumor growth, dissemination and metastasis. For metastasis, the transendothelial migration of the tumor cells is a critical step, however, the endothelial regulatory elements of this step remain obscure. We present data demonstratin [....] » Read More

Constantinos M. Mikelis, University of Patras, Greece

Oral Presentation (Virtual)

Lorent Sijarina, Speaker at Cancer Science and Research Conference

Title: Applying the concept of "Lean Management": evaluation of a pioneer off-site injection program for androgen deprivation treatment of prostate cancer

Purpose: Due to the large number of prostate cancer patients who require androgen deprivation therapy (ADT), and the frequent monthly administration of a new gonadotropin-releasing hormone (GnRH) antagonist, our province pioneered off-site injection programs in Regina, which is t [....] » Read More

Lorent Sijarina, University of Prishtina, Kosovo

Oral Presentation (Virtual)

Prema Naittee George, Speaker at Oncology Conference

Title: The paradox of spirituality: Its impact on social wellbeing in aya cancer survivors

Background: Cancer survivors often embark on a challenging journey towards physical and emotional recovery, seeking various avenues to enhance their overall well-being. Among these avenues, spirituality has gained recognition as a coping mechanism that provides solace and purpose [....] » Read More

Prema Naittee George, Gitam University, India

Oral Presentation (Virtual)

Viacheslav Artyushenko, Speaker at Oncology Conference

Title: Innovative fiber solutions for cancer diagnostics

The latest innovative fiber solutions to be reviewed for the advanced biomedical applications in 0.3- 16µm range, including multispectral diagnostics to define tumor margins in oncology ex-vivo and in- vivo, plus tumor detection with IR-fiber and Raman endoscopy.   [....] » Read More

Viacheslav Artyushenko, Art photonics GmbH, Germany

Oral Presentation (Virtual)

Omar Mohammad Alqaisi , Speaker at Oncology Conference

Title: Immunotherapy in merkel cell carcinoma of the skin: A 2025 comprehensive review

Purpose: Merkel cell carcinoma (MCC) is a rare and aggressive form of skin cancer. Although immunotherapy has transformed MCC management, published data remains limited. This comprehensive review evaluates current evidence on immunotherapy in MCC. Methods: Peer-reviewed articles [....] » Read More

Omar Mohammad Alqaisi , Al- Zaytoonah University, Jordan

Oral Presentation (Virtual)

Aurelian Udristioiu, Speaker at Oncology Conference

Title: Application of CRISPR–Cas9 technology in the treatment of chronic lymphocytic leukemia with TP53 mutations

Aim This study proposes the implementation of clustered regularly interspaced short palindromic repeats (CRISPR)–CRISPR-associated protein 9 (Cas9) technology for gene therapy targeting genetic mutations in human lymphocytes affected by chronic lymphocytic leukemia, (CLL [....] » Read More

Aurelian Udristioiu, Titu Maiorescu University of Bucharest, Romania

Oral Presentation (Virtual)

Patricia Tai, Speaker at Oncology Conference

Title: A narrative review on the roles of nursing in sexual dysfunction among oncological patients with updated recommendations

Background Sexual dysfunction is a prevalent yet often overlooked issue among cancer patients, significantly affecting their quality of life, emotional well-being, and intimate relationships. Despite the high prevalence (87%) of sexual dysfunction among cancer survivors, it r [....] » Read More

Patricia Tai, University of Saskatchewan, Canada

Oral Presentation (Virtual)

Omar Mohammad Alqaisi , Speaker at Oncology Conference

Title: Managing sexual issues in melanoma patients: A scoping review

Background Managing sexual issues in melanoma patients involves addressing both physical and psychological changes that may arise during or after treatment. Although melanoma itself may not directly affect sexual function, treatments such as radiotherapy, immunotherapy, targe [....] » Read More

Omar Mohammad Alqaisi , Al- Zaytoonah University, Jordan

Oral Presentation (Virtual)

Patricia Tai, Speaker at Oncology Conference

Title: Oncology nurses’ attitudes, knowledge and practices in providing sexuality care to cancer patients: A scoping review

Sexual health in cancer care is often overlooked. This study examines oncology nurses’ knowledge and practices regarding sexuality care, identifying barriers and facilitators. A Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA)-guided search of Sco [....] » Read More

Patricia Tai, University of Saskatchewan, Canada

Oral Presentation (Virtual)

Anyou Wang, Speaker at Cancer Science and Research Conference

Title: Theory and perspective: Big data and artificial intelligence accelerate the pursuit of a universal cancer principle—opportunities and challenges

Although numerous cancer-associated mechanisms are reported on a daily basis, the establishment of a unifying theoretical framework capable of explaining and ultimately eradicating all cancers remains unresolved. Emerging advances in big data analytics and artificial intelligence [....] » Read More

Anyou Wang, DIFIBER LLC, United States

Oral Presentation (Virtual)

Dmitri Lapotko, Speaker at Oncology Conference

Title: Instant high-sensitivity non-invasive in-vivo diagnosis during biopsy

Today, doctors have to wait until the tumor grows large enough to become detectable. At this stage, it is often too late to cure. Biopsy, the gold standard in cancer diagnostics, cannot detect tumors in real-time, is often invasive, and frequently misses microscopic-size tumors. [....] » Read More

Dmitri Lapotko, Scorpido Photonics, Inc, United States

Oral Presentation (Virtual)

Debi Lynn, Speaker at Cancer Science and Research Conference

Title: Beyond survival: The silent struggle of living after cancer

Let me tell you about a woman I loved. She was strong, brave, and relentless. She beat cancer not once, not twice, but three times. From the outside, it looked like victory. Yet her story did not end in celebration. Her third diagnosis took more than her health. It took her abili [....] » Read More

Debi Lynn, Business Resilience Strategist and Certified Grief Educator, United States

Oral Presentation (Virtual)

Chanda Siddoo-Atwal, Speaker at Oncology Conference

Title: Is cancer theory incomplete?

According to one physicist, major advances in science arise from two sources. The first is the introduction of new data and the second is the study of inconsistencies in established knowledge. Has cancer research missed the boat? Classically, experimental carcinogenesis is a comp [....] » Read More

Chanda Siddoo-Atwal, Moondust Cosmetics Ltd, Canada

Oral Presentation (Virtual)

Tanja Obradovic, Speaker at Cancer Conferences

Title: Strategic development of novel cancer immunotherapies – medical strategy toward regulatory success

Over the past decade checkpoint inhibitors directed against the programmed death ligand 1 (PD-L1) emerged as major therapeutic advance across numerous tumor indications. While immunotherapy with PD-L1 inhibitors achieved durable responses and long-term survival in many patients s [....] » Read More

Tanja Obradovic, Arc Nouvel LLC, United States

Oral Presentation (Virtual)

Janusz Rak, Speaker at Oncology Conference

Title: Extracellular vesicle pathways as regulators of tumor-vascular interactions in glioblastoma

Glioblastoma (GBM), the most prevalent astrocytic brain tumour, remains incurable in spite of decades of research. Florid neovascularization, a morphological hallmark of GBM, is still poorly understood, as is the role of blood vessels in mediating the access of immune cells into [....] » Read More

Janusz Rak, McGill University, Canada

Oral Presentation (Virtual)

Mahwish Fatima, Speaker at Oncology Conference

Title: Anticancer effect of patuletin on neuroblastoma cell line SH-SY5Y

Neuroblastoma is an extracranial solid tumor, usually found in children, and one of the most common pediatric cancers. It originates from the neural crest cells of the sympathetic nervous  system. While multimodal therapies: including chemotherapy, radiotherapy, surgery, and [....] » Read More

Mahwish Fatima, Aga Khan University Karachi, Pakistan

Poster Presentation (Virtual)

Nabhan Linda, Speaker at Oncology Conference

Title: Cardiac coherence: A new approach to oncology medicine

In the oncology clinic, the issue of anguish, stress and anxiety is a very important part of treatment. These affects can also condition the outcome of treatment, as well as patients' experiences of their disease. Cancer has specific psychological repercussions compared with [....] » Read More

Nabhan Linda, OncopsyHeart Mindcare Collective, France

Poster Presentation (Virtual)

Karishma Shelley, Speaker at Cancer Science and Research Conference

Title: Time and cost to healthcare providers and sites associated with preparation and administration of subcutaneous vs intravenous nivolumab for the treatment of cancer: a time-driven activity-based costing study

Background: Subcutaneous (SC) administration of oncology therapies offers increased convenience for patients and healthcare providers (HCPs) and reduced administration costs when compared with intravenous (IV) delivery. SC nivolumab (NIVO), in combination with hyaluronidase-nvhy [....] » Read More

Karishma Shelley, Bristol Myers Squibb, United States

Keynote Presentation (Virtual)

Marika Crohns, Speaker at Oncology Conference

Title: Intelligent oncology: The transformative role of AI in the future of cancer research and care

Artificial Intelligence (AI) is poised to revolutionize oncology by transforming how we detect, understand, and treat cancer. As cancer remains a leading cause of death globally, integrating AI into research and clinical workflows offers unprecedented opportunities to address its [....] » Read More

Marika Crohns, Impactful Innovations Management Consultants LLC, Dubai, UAE

Oral Presentation (Virtual)

Sarantis Gagos, Speaker at Oncology Conference

Title: Targeting alternative lengthening of telomeres in cancer

Telomeres have a double role in neoplasia. These highly conserved repetitive nucleoprotein structures that protect the ends of chromosomes safeguard somatic cells from tumorigenic mutations and prevent cancer. However, most tumors bypass replicative senescence and support maligna [....] » Read More

Sarantis Gagos, Biomedical Research Foundation of the Academy of Athens (BRFAA), Greece

Oral Presentation (Virtual)

Alexandru Calin Grigorescu, Speaker at Oncology Conference

Title: Association between lung cancer and prostate cancer, 3 studied cases, short literature review

Background: The association of lung cancer with prostate cancer is little studied. In the Medscape site we do not have any reference to this association.   Material and method: We have collected data from 3 concrete cases regarding this association and we evaluated the [....] » Read More

Alexandru Calin Grigorescu, Clinical Hospital for Nephrology "Dr Carl Davila", Romania

Oral Presentation (Virtual)

Stephan Bodis, Speaker at Cancer Science and Research Conference

Title: An Eternal Moment (A Patient's Feedback to Medical Care Givers)

Purpose/Objective(s): Narrative Oncology can describe relevant components of a patient and health care staff interaction in a complimentary way. Fictitious microstories can provide such critical information in a concise way and respect the anonymity both of health care staff a [....] » Read More

Stephan Bodis, University Zurich, Switzerland

Oral Presentation (Virtual)

Nicola Sarandria, Speaker at Cancer Science and Research Conference

Title: Dr Nicola Sarandria’s Theory of Arginase-1 and N2 neutrophil’s Role in Rectal Cancer based on the 2025 OR1 Research Study directed by Dr Nicola Sarandria: New insights on the relationship between Arginase-1, Tumor Associated Neutrophils, Perineural Invasion, Neoadjuvant therapy and Prognosis in Rectal Cancer Patients

Introduction Rectal cancer is one of the most common cancers with a high epidemiologic burden. Need for new prognostic and predictive indicators and therapies is urgent in the field to improve clinical outcomes and gather a better understanding of the disease. Indicators such [....] » Read More

Nicola Sarandria, Olimpia Medical Center, Italy

Oral Presentation (Virtual)

Bep Dhaliwal, Speaker at Cancer Science and Research Conference

Title: The power of trust through the eyes of a patient

One of the first things to be impacted when a patient receives a cancer diagnosis is Trust. Trust in their body, in the world as they see it and very quickly they need to learn to build trust in their clinicians and the proposed pathways to tackle one of the toughest experiences [....] » Read More

Bep Dhaliwal, Patient Advocate, United Kingdom

Oral Presentation (Virtual)

Iveta Herichová, Speaker at Oncology Conference

Title: Daily profile in miRNA expression in the colon and their role in colorectal cancer

Colorectal cancer (CRC) belongs among the most frequently diagnosed malignancies and its progression is strongly influenced by miRNAs as well as the circadian system. With the use of high-throughput sequencing of miRNAs expressed in the rat colon during 24h light (L) dark (D) cyc [....] » Read More

Iveta Herichová, Comenius University in Bratislava, Slovakia (Slovak Republic)

Oral Presentation (Virtual)

K R Muralidhar, Speaker at Oncology Conference

Title: Expanding the reach: Integrating AI-generated auto contours via deep learning segmentation into diverse treatment planning systems

Aim: Contouring in treatment planning systems for radiation oncology plays a crucial role in ensuring accurate and effective treatment. The integration of AI-generated auto-contouring with other planning systems, particularly in remote areas, is essential for achieving optimal co [....] » Read More

K R Muralidhar, Physics Karkinos Healthcare Private Limited, India

Oral Presentation (Virtual)

Saba Beigh, Speaker at Cancer Science and Research Conference

Title: Comprehensive pharmacokinetic profiling and molecular docking analysis of natural bioactive compounds targeting oncogenic biomarkers in breast cancer

Breast cancer remains a leading cause of mortality in women worldwide, emphasizing the need for novel, safe, and effective therapeutic strategies. This study investigates the potential of four natural bioactive compounds—Berberine, Curcumin, Withaferin A, and Ellagic Acid&m [....] » Read More

Saba Beigh, Al-Baha University, Saudi Arabia

Oral Presentation (Virtual)

Dharmendra Kumar, Speaker at Oncology Conference

Title: Nanoparticle-based therapeutic platforms: Development and evaluation for cancer treatment

Polymeric nanoparticles are widely explored for drug delivery, though challenges remain in drug loading, entrapment, and release. In this study, starch nanoparticles were prepared from unripe banana fruit, which contains amylose (26–28%) and amylopectin (72–74%). Amyl [....] » Read More

Dharmendra Kumar, Swami Vivekanand Subharti University, India

Oral Presentation (Virtual)

Drilon Bytyci, Speaker at Cancer Science and Research Conference

Title: Difficult-to-manage prostate cancer scenarios illustrating the pathologist’s role: Two case reports

Background: Prostate cancer remains one of the most common malignancies among men worldwide, and its diagnosis and management rely fundamentally on accurate histopathologic evaluation. Gleason grading, now incorporated into the ISUP Grade Group system, is central to determining [....] » Read More

Drilon Bytyci, University of Prishtina, Kosovo

Oral Presentation (Virtual)

Fatlinda Berisha, Speaker at Cancer Science and Research Conference

Title: Overview of PSMA PET and salvage treatment of previously irradiated recurrent prostate cancers

Background: Prostate cancer is prevalent in the United States and often spotlighted due to celebrity diagnoses. Recurrent prostate cancer remains a major clinical challenge, typically first indicated by a rising prostate-specific antigen (PSA) level. PSA serves as a reliable b [....] » Read More

Fatlinda Berisha, University of Pristina, Kosovo

Oral Presentation (Virtual)

Drilon Bytyci, Speaker at Cancer Science and Research Conference

Title: Updates on prostate cancer

Background: Prostate cancer remains one of the most prevalent malignancies in men, significantly contributing to global morbidity, mortality, and healthcare costs. Advances in diagnostics and treatment over the past decade have reshaped management strategies. Methods: A lite [....] » Read More

Drilon Bytyci, University of Prishtina, Kosovo

Oral Presentation (Virtual)

Liburn Grabovci, Speaker at Cancer Science and Research Conference

Title: Improving quality of life among cancer patients in the modern era

Introduction: Modern cancer treatments often lead to a wide range of acute side effects, such as nausea, fatigue, pain, and infections that significantly impair daily functioning. Long-term complications, including neuropathy, hormonal imbalances, infertility, and emotional di [....] » Read More

Liburn Grabovci, University of Pristina, Kosovo

Oral Presentation (Virtual)

Viviana C. Blank, Speaker at Oncology Conference

Title: Synergistic antitumor effects of 2NF and safingol combination in breast cancer: Molecular mechanisms involving SPHK1, MAPKs, and ER stress

Background The sphingosine kinase 1 (SphK1)/sphingosine-1-phosphate (S1P) axis has been widely studied in cancer research due to its role in modulating sphingolipid metabolism, which determines cell survival or death. Furthermore, SphK1 inhibitors prevent catabolism of ceram [....] » Read More

Viviana C. Blank, University of Buenos Aires, Argentina

Oral Presentation (Virtual)

Gaurav Vishal, Speaker at Oncology Conference

Title: Analysis of 64 cases of oral squamous cell carcinoma of the buccal mucosa

Introduction: Squamous cell carcinoma of the buccal mucosa is the most common oral cavity cancer in Southeast Asia. In India, 60 to 80% of oral squamous cell carcinoma cases present with advanced stage as compared to 40% in developed countries. Carcinoma of the buccal mucosa is t [....] » Read More

Gaurav Vishal, Prathima Cancer Institute, India

Oral Presentation (Virtual)

Eleni Petsalaki, Speaker at Oncology Conference

Title: A new tension-sensitive signaling pathway involving polymerization of actin prevents chromatin bridge breakage in cytokinesis in human cancer cells

Chromatin bridges are strands of incompletely segregated DNA connecting the anaphase poles or daughter nuclei. Chromatin bridges can arise from incompletely replicated DNA, defective resolution of DNA catenates or dicentric chromosomes which are formed by chromosome fusions. If u [....] » Read More

Eleni Petsalaki, University of Crete, Greece

Oral Presentation (Virtual)

Yasmeen Idrees, Speaker at Oncology Conference

Title: How can developing countries improve survival rates of glioma patients

Background: Gliomas represent one of the most challenging brain malignancies with historically poor survival outcomes, particularly in developing countries where healthcare infrastructure limitations significantly impact patient care and treatment accessibility. Our objective is [....] » Read More

Yasmeen Idrees, Lifecare Hospital Lahore, Pakistan

Oral Presentation (Virtual)

Liburn Grabovci, Speaker at Cancer Science and Research Conference

Title: Updates on CNS tumors

Background: Central nervous system (CNS) tumors are categorized as primary or secondary, with metastatic tumors being more common. They contribute significantly to morbidity and mortality. Over the past decade, notable advances have emerged in their management. Methods: [....] » Read More

Liburn Grabovci, University of Pristina, Kosovo

Oral Presentation (Virtual)

Can Küçük, Speaker at Oncology Conference

Title: The transcriptional regulator PRDM1: Key insights into its role in NK cell homeostasis and malignancy

Natural killer cell lymphoma (NKCL) is an aggressive type of cancer with poor prognosis. As a rare cancer type with geographic predilection, it was of utmost significance to identify the cancer- associated genes contributing to development of NKCL. Our previous study revealed rec [....] » Read More

Can Küçük, Dokuz Eylül University, Turkey

Oral Presentation (Virtual)

Melinda Hysenaj, Speaker at Oncology Conference

Title: Oncologic emergencies – a narrative review with expert opinions and latest recommendations

Introduction: Oncologic emergencies are some of the most critical and time-sensitive situations clinicians can face in cancer care. These events, ranging from metabolic imbalances to spinal cord compression or life-threatening infections, can progress rapidly and require immed [....] » Read More

Melinda Hysenaj, University of Prishtina, Kosovo

Oral Presentation (Virtual)

Yasmeen Idrees, Speaker at Oncology Conference

Title: Improving survival rates of glioma patients in developing countries

Background: Gliomas represent one of the most challenging brain malignancies with historically poor survival outcomes, particularly in developing countries where healthcare infrastructure limitations significantly impact patient care and treatment accessibility.   Obje [....] » Read More

Yasmeen Idrees, Lifecare Hospital Lahore, Pakistan

Oral Presentation (Virtual)

Anu Jose, Speaker at Oncology Conference

Title: Well differentiated liposarcoma of face: An unusual case report

Background:  Liposarcoma’s are rarely reported in the head and neck region. The lacking literature evidence of this particular entity makes the clinical identification and treatment decision very challenging. Here we present a case of liposarcoma in a 95 year old femal [....] » Read More

Anu Jose, The University Hospital of West Indies, Jamaica

Oral Presentation (Virtual)

Zare Hamed, Speaker at Cancer Science and Research Conference

Title: Investigating the combined effects of paclitaxel and pirfenidone on metastasis in triple-negative breast cancer (TNBC) cells

Triple-negative breast cancer (TNBC) is a subtype of breast cancer characterized by the absence of estrogen receptor, progesterone receptor, and HER2 expression, making it unresponsive to conventional hormonal therapies. TNBC is associated with poor prognosis, rapid recurrence, a [....] » Read More

Zare Hamed, Motamed Cancer Institute, Iran (Islamic Republic of)

Oral Presentation (Virtual)

Melisa Stublla, Speaker at Cancer Science and Research Conference

Title: Colorectal cancer screening

Introduction: Colorectal cancer is one of the leading causes of cancer-related mortality worldwide. In many cases, diagnosis occurs at late stages, which negatively affects survival outcomes. Due to its slow progression through precancerous lesions, CRC is particularly amenable t [....] » Read More

Melisa Stublla, University of Prishtina, Kosovo

Copyright 2024 Mathews International LLC All Rights Reserved

Watsapp
Top